Follow
Zoltán Kaló
Zoltán Kaló
Center for Health Technology Assessment, Semmelweis University; Syreon Res
Verified email at semmelweis-univ.hu - Homepage
Title
Cited by
Cited by
Year
Multiple criteria decision analysis for health care decision making—an introduction: report 1 of the ISPOR MCDA Emerging Good Practices Task Force
P Thokala, N Devlin, K Marsh, R Baltussen, M Boysen, Z Kalo, ...
Value in health 19 (1), 1-13, 2016
7122016
Multiple criteria decision analysis for health care decision making—emerging good practices: report 2 of the ISPOR MCDA Emerging Good Practices Task Force
K Marsh, M IJzerman, P Thokala, R Baltussen, M Boysen, Z Kaló, ...
Value in health 19 (2), 125-137, 2016
4702016
The life‐years saved by a deceased organ donor
MA Schnitzler, JF Whiting, DC Brennan, KL Lentine, NM Desai, ...
American Journal of Transplantation 5 (9), 2289-2296, 2005
1612005
Comparison of weighting methods used in multicriteria decision analysis frameworks in healthcare with focus on low-and middle-income countries
B Németh, A Molnár, S Bozóki, K Wijaya, A Inotai, JD Campbell, Z Kaló
Journal of comparative effectiveness research 8 (4), 195-204, 2019
1402019
Cost-effectiveness of organ donation: evaluating investment into donor action and other donor initiatives
JF Whiting, B Kiberd, Z Kalo, P Keown, L Roels, M Kjerulf
American Journal of Transplantation 4 (4), 569-573, 2004
1342004
The expanded criterial donor dilemma in cadaveric renal transplantation
MA Schnitzler, JF Whiting, DC Brennan, G Lin, W Chapman, J Lowell, ...
Transplantation 75 (12), 1940-1945, 2003
1312003
Challenges in research and health technology assessment of rare disease technologies: report of the ISPOR rare disease special interest group
S Nestler-Parr, D Korchagina, M Toumi, CL Pashos, C Blanchette, ...
Value in Health 21 (5), 493-500, 2018
1172018
The cost effectiveness of Apligraf® treatment of diabetic foot ulcers
WK Redekop, J McDonnell, P Verboom, K Lovas, Z Kalo
Pharmacoeconomics 21, 1171-1183, 2003
1022003
HTA implementation roadmap in Central and Eastern European countries
Z Kaló, A Gheorghe, M Huic, M Csanádi, FB Kristensen
Health economics 25, 179-192, 2016
942016
Diabetic foot ulcers and amputations: estimates of health utility for use in cost-effectiveness analyses of new treatments
WK Redekop, EA Stolk, E Kok, K Lovas, Z Kalo, JJV Busschbach
Diabetes & metabolism 30 (6), 549-556, 2004
912004
Principles of pharmacoeconomics and their impact on strategic imperatives of pharmaceutical research and development
J Bodrogi, Z Kaló
British journal of pharmacology 159 (7), 1367-1373, 2010
862010
Resource use and treatment costs after kidney transplantation: impact of demographic factors, comorbidities, and complications
EG Hagenmeyer, B Häussler, E Hempel, G Grannas, Z Kaló, A Kilburg, ...
Transplantation 77 (10), 1545-1550, 2004
792004
Capacity building for HTA implementation in middle-income countries: the case of Hungary
Z Kaló, J Bodrogi, I Boncz, C Dózsa, G Jóna, R Kövi, Z Pásztélyi, ...
Value in health regional issues 2 (2), 264-266, 2013
782013
Systematic review on the evaluation criteria of orphan medicines in Central and Eastern European countries
T Zelei, MJ Molnár, M Szegedi, Z Kaló
Orphanet journal of rare diseases 11, 1-11, 2016
712016
Is there a reason for concern or is it just hype?–A systematic literature review of the clinical consequences of switching from originator biologics to biosimilars
A Inotai, CPJ Prins, M Csanádi, D Vitezic, C Codreanu, Z Kaló
Expert opinion on biological therapy 17 (8), 915-926, 2017
662017
Cost‐effectiveness analysis of intensity‐modulated radiation therapy with normal and hypofractionated schemes for the treatment of localised prostate cancer
AT Zemplényi, Z Kaló, G Kovacs, R Farkas, T Beöthe, D Bányai, ...
European Journal of Cancer Care 27 (1), e12430, 2018
652018
Differential pricing of new pharmaceuticals in lower income European countries
Z Kaló, L Annemans, LP Garrison
Expert review of pharmacoeconomics & outcomes research 13 (6), 735-741, 2013
652013
Economic evaluation of kidney transplantation versus hemodialysis in patients with end-stage renal disease in Hungary
Z Kaló, J Járay, J Nagy
Progress in Transplantation 11 (3), 188-193, 2001
642001
Recommendations for reporting pharmacoeconomic evaluations in Egypt
GH Elsisi, Z Kaló, R Eldessouki, MD Elmahdawy, A Saad, S Ragab, ...
Value in health regional issues 2 (2), 319-327, 2013
622013
Development of health economics in Hungary between 1990-2006
I Boncz, C Dózsa, Z Kaló, L Nagy, B Borcsek, Á Brandtmüller, J Betlehem, ...
The European Journal of Health Economics, S4-S6, 2006
592006
The system can't perform the operation now. Try again later.
Articles 1–20